Treatment

AdVince clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Neoplasms; Safety and Efficacy (RADNET)
This study is testing a new treatment called AdVince for a type of cancer called neuroendocrine neoplasms (NENs). It's the first time this treatment is being given to people. Researchers want to see if it's safe and if it can help slow down or shrink the cancer.
For: Neuroendocrine neoplasms (NENs) is a heterogeneous group with varying symptoms · tumor biology and treatment response. NENs may occur in any organ · most commonly they are observed in the gastroenteropancreatic system and lungs. Most NEN patients are diagnosed at advanced stage
Sweden